New prospects for luteinising hormone releasing hormone as a contraceptive and therapeutic agent.

This publication has 13 references indexed in Scilit:

• “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.
  Journal of Clinical Endocrinology & Metabolism, 1982
• SUSTAINED SUPPRESSION OF TESTOSTERONE PRODUCTION BY THE LUTEINISING-HORMONE RELEASING-HORMONE AGONIST BUSERELIN IN PATIENTS WITH ADVANCED PROSTATE CARCINOMA
  The Lancet, 1982
• TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCER
  The Lancet, 1982
• Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.
  Proceedings of the National Academy of Sciences, 1982
• Testosterone Secretion by Cultured Arrhenoblastoma Cells: Suppression by a Luteinizing Hormone-Releasing Hormone Agonist
  Journal of Clinical Endocrinology & Metabolism, 1982
• Short-Term Treatment of Idiopathic Precocious Puberty with a Long-Acting Analogue of Luteinizing Hormone-Releasing Hormone
  New England Journal of Medicine, 1981
• EFFECT OF OESTROGEN ON GONADOTROPHIN RELEASE IN STUMPTAILED MONKEYS (MACACA ARCTOIDES) TREATED CHRONICALLY WITH AN AGONIST ANALOGUE OF LUTEINIZING HORMONE RELEASING HORMONE
  Journal of Endocrinology, 1981
• Reversible Inhibition of Testicular Steroidogenesis and Spermatogenesis by a Potent Gonadotropin-Releasing Hormone Agonist in Normal Men
  New England Journal of Medicine, 1981
• Inhibition of the action of sex steroids by gonadotropin-releasing hormone (GnRH) agonists: A new biological effect
  Life Sciences, 1981
• Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen.
  BMJ, 1977